Quadriceps Strength Linked to Lower Risk for Heart Failure After AMI
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, May 26, 2023 -- A higher level of quadriceps isometric strength (QIS) is associated with a lower risk for developing heart failure after acute myocardial infarction (AMI), according to a study presented at the European Society of Cardiology Heart Failure 2023, held from May 20 to 23 in Prague.
Kensuke Ueno, P.T., from the Kitasato University Graduate School of Medical Sciences in Sagamihara, Japan, and colleagues examined the association between QIS, as a measure of skeletal muscle strength, and the risk for developing heart failure among 932 AMI patients without a history of heart failure or complications of heart failure during hospitalization.
The researchers found that 67 patients (7.2 percent) developed heart failure during an average follow-up of 4.5 years. The incidence of heart failure was 10.2 and 22.9 per 1,000 person-years in patients with high and low quadriceps strength, respectively. In adjusted analyses, a high QIS level was associated with a significantly lower risk for developing heart failure compared with low QIS (hazard ratio, 0.59). Each 5 percent body weight increment in QIS was associated with a lower likelihood of heart failure (hazard ratio, 0.89).
"Quadriceps strength is easy and simple to measure accurately in clinical practice. Our study indicates that quadriceps strength could help to identify patients at a higher risk of developing heart failure after myocardial infarction who could then receive more intense surveillance," Ueno said in a statement. "The findings need to be replicated in other studies, but they do suggest that strength training involving the quadriceps muscles should be recommended for patients who have experienced a heart attack to prevent heart failure."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2023
Read this next
Semaglutide Reduces Need for Diuretics in Heart Failure
THURSDAY, May 16, 2024 -- Semaglutide reduces the need for loop diuretics and has positive effects on symptoms, physical limitations, and body weight in patients with heart...
Male, Female V1421 Carriers Face Similar Risk for Heart Failure Hospitalization
THURSDAY, May 16, 2024 -- Male and female V1421 carriers face a similar and substantial risk for heart failure hospitalization, according to a study published online May 12 in the...
Women, Black and Hispanic Adults Have Lower Angiography/PCI Use in NSTEMI
THURSDAY, May 16, 2024 -- Disparities are evident in the interventional management of non-ST-segment elevated myocardial infarction (NSTEMI) and in STEMI incidence and mortality...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.